US regulators will certify first small nuclear reactor design
NuScale will get the final approval nearly six years after starting the process.
Science // Science & Exploration
As BA.5 continues to blaze across US, feds scrap summer booster plans
Officials are focusing on bivalent fall boosters, which may be ready in September.
Inflating spider corpse creates robotic claw game of nightmares
Welcome to the exciting, rather macabre new field of "necrobotics."
Genetically engineered rice needs less fertilizer, makes more food
The change coupled enhanced photosynthesis with improved nitrogen use.
DeepMind research cracks structure of almost every known protein
Breakthrough by AI company will reduce time required to make biological discoveries.
Record-breaking UK heat “extremely unlikely” without climate change
Rapid analysis of the role of climate change finds clear relationship.
Russia: We’re not leaving the Space Station until our own is ready
Both NASA and Roscosmos are now saying Russia's departure won't be soon.
Monkeypox spreading via direct, physical contact, CDC says as US cases hit 45
CDC worked to raise awareness, dispel concerns of airborne transmission.
Diving brothers found the wreck of the Gloucester 300+ years after sinking
The most significant historic maritime discovery since raising the Mary Rose in 1982.
US can’t afford fall boosters for all—even after cuts to test and PPE spending
"These were incredibly painful decisions."
NASA to figure out how to get data on unexplained objects in the sky
Agency is commissioning a report on how to get data on "unidentified aerial phenomena."
Quantum computer succeeds where a classical algorithm fails
Quantum computers coupled with traditional machine learning show clear benefits.
NASA’s second mobile launcher is too heavy, years late, and pushing $1 billion
"We found Bechtel's poor performance is the main reason."
Rocket Report: Four Falcon Heavy launches this year; meet the Baguette-one
Will we soon hear about SpaceX's proposed launch site in South Texas?
Moderna’s omicron-combo booster outcompetes current booster
Antibody data looks strong, but duration and subvariant effectiveness are unknown.
